Software plans

Choose a software licence for your data-analysis and research workflow. Request access to confirm availability, the included features and the licence terms.

MBO Analyzer

Every plan is for research and simulation. Simulated trading runs inside the software; no plan places real-money orders, trades on a broker's demo account, copies trades or delivers trading signals.

Trial

Free14 days

Try the Pro research features for 14 days on one computer. No card required.

  • MetaTrader 5 tick-data backtests
  • Strategy and indicator library
  • Real-time market data with simulated trading
  • Direct order-book data feed
  • Market-data recording
  • Parameter sweeps and advanced backtest analysis
  • Library uploads
  • 1 computer
  • No payment card required
Request trial access

Basic

Request a quote

Recorded-data analysis and simulated backtesting.

  • MetaTrader 5 tick-data backtests
  • Strategy and indicator library
  • 1 computer
Request Basic details

Trial details

The trial runs for 14 days on one computer and does not need a payment card. We will confirm when the trial begins and which features are included. When it ends, the trial features stop working; nothing is charged and nothing renews.

Real-time market data

On plans that include it, the software can connect to a supported real-time data feed for analysis and simulated trading. You need your own access with the data provider; its permissions and charges are separate from the software licence. The data connection never submits orders.

Confirm your licence before activation

Before any paid licence, our written offer sets out the features, price and currency, applicable taxes, licence period, number of computers and any renewal, cancellation or refund terms. Review that offer and the software terms before accepting.

Licence activation by request

There is no online checkout. Send a software-access request and we will reply by email about availability and the next steps, or write to support@forexexp.com.

A software licence buys access to the stated software features. It does not promise investment results, profitable strategies or equivalent real-market execution. Read the research and risk notice.